Evidence map›Paper›PMID 39695973›Full record

ArticleBMC infectious diseases2024

Clinical characteristics and prediction model of re-positive nucleic acid tests among Omicron infections by machine learning: a real-world study of 35,488 cases.

Ying Cao, Tianhua Yao, Ronghao Li, Liang Tan, Zhixiong Zhang, Junsheng Qi, Rui Zhang, Yazhou Wu, Zhiqiang Chen, Changlin Yin

Abstract read
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ying CaoDepartment of Critical Care Medicine, The first affiliated hospital(Southwest Hospital), Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Tianhua YaoDepartment of Health Statistics, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University), No. 30, Gaotan Yanzheng Street, Shapingba District, Chongqing, 400038, China.
Ronghao LiSchool of Basic Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Liang TanDepartment of Critical Care Medicine, The first affiliated hospital(Southwest Hospital), Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Zhixiong ZhangSchool of Basic Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Junsheng QiDepartment of Critical Care Medicine, The first affiliated hospital(Southwest Hospital), Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Rui ZhangDepartment of Critical Care Medicine, The first affiliated hospital(Southwest Hospital), Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Yazhou WuDepartment of Health Statistics, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University), No. 30, Gaotan Yanzheng Street, Shapingba District, Chongqing, 400038, China. asiawu@tmmu.edu.cn.
Zhiqiang ChenDepartment of Pediatrics, The first affiliated hospital(Southwest Hospital), Army Medical University (Third Military Medical University), No. 30, Gaotan Yanzheng Street, Shapingba District, Chongqing, 400038, China. chenzhiqiang_cc@163.com.
Changlin YinDepartment of Critical Care Medicine, The first affiliated hospital(Southwest Hospital), Army Medical University (Third Military Medical University), Chongqing, 400038, China. ycl0315@163.com.

Funding

Chongqing Natural Science Foundation CSTB2023NSCQ-MSX1029Senior Medical Talents Program of Chongqing for Young and Middle-aged, the Young and Middle-aged Senior Medical Talents studio of Chongqing, the Chongqing Science-health joint medical research project 2022QNXM27the DZ Hospital construction project by Southwest Hospital 2022DZXDX001
6 · The paper itself

Abstract

backgroundDuring the Omicron BA.2 variant outbreak in Shanghai, China, from April to May 2022, PCR nucleic acid test re-positivity (TR) occurred frequently, yet the risk factors and predictive models for TR remain unclear. This study aims to identify the factors influencing Omicron TR and to develop machine learning models to predict TR risk. Accurately predicting re-positive patients is crucial for identifying high-risk individuals, optimizing resource allocation, and developing personalized treatment and management plans, thereby effectively controlling the spread of the epidemic, reducing community burden, and ensuring public health.

methodsA retrospective study was conducted among individuals infected with Omicron BA.2 variant from April 12 to May 25, 2022, in the largest Shanghai Fangcang shelter hospital. Five machine learning models were compared, including k-nearest-neighbors (KNN), logistic regression (logistic), bootstrap aggregation (bagging), error back-propagation (BP) neural network, and support vector machines (SVM), to select the best prediction model for the TR risk factors.

resultsA total of 35,488 cases were included in this real-world study. The TR and control groups comprised of 6,171 and 29,317 cases respectively, with a re-positive rate of 17.39%. Higher occurrence of TR was observed in young age, males, those with obvious symptoms, underlying diseases, and a low Ct value. The KNN model proved to be the best in predicting the prognosis in the overall evaluation (accuracy = 0.8198, recall = 0.8026, and AUC = 0.8110 in the test set).

interpretationHigher TR risk was found in infected cases who were underage or with underlying diseases; vaccine brand and inoculation status were not significantly associated with TR. KNN was the most effective machine learning model to predict TR occurrence in isolation.

Indexed as

COVID-19Machine LearningSARS-CoV-2AdolescentAdultAgedAged, 80 and overChildChild, PreschoolChinaCOVID-19 Nucleic Acid TestingFemaleHumansInfantMaleMiddle AgedCOVID-19Decision-makingMachine learningOmicronRe-positive

Identifiers

PMID39695973
PMCPMC11654198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.